Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
14.96
+0.29 (1.98%)
Apr 28, 2025, 2:45 PM CST
-11.90%
Market Cap 8.00B
Revenue (ttm) 3.14B
Net Income (ttm) -197.17M
Shares Out 545.46M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE 293.40
Dividend 0.49 (3.32%)
Ex-Dividend Date May 29, 2024
Volume 11,062,656
Average Volume 18,643,392
Open 14.66
Previous Close 14.67
Day's Range 14.53 - 15.05
52-Week Range 10.91 - 21.98
Beta 0.64
RSI 45.54
Earnings Date Mar 29, 2025

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. The company operates in China and internationally. The company was formerly known as Porton Fine Ch... [Read more]

Sector Healthcare
Founded 2005
Employees 4,915
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.